Evalution of the effect of combination therapy with extract of Bunium Persicum and Foeniculum Vulgare on clinical features in Polycystic Ovary Syndrome (PCOS) patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120709010222N20

Enrollment

Registered

2018-11-14

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pcos. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: In addition to routine drugs,receive the combination of extract of Bunium Persicum and Foeniculum Vulgare for four months twice a day. Intervention 2: Control group

Eligibility

Sex/Gender

Female

Age

16 Years to 40 Years

Inclusion criteria

Inclusion criteria: Polycystic ovary syndrome

Exclusion criteria

Exclusion criteria: History of drug use for PCOS Ocp users No regular use of herbal medicine

Design outcomes

Primary

Measure	Time frame
Menstrual pattern. Timepoint: every months. Method of measurement: checklist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBelghese Mohammadi

Shahre-kord University of Medical Sciences

mohammadi.b@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026